Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Patients With Cancer or Precancerous Conditions
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), April 2008
First Received: March 7, 2007   Last Updated: February 6, 2009   History of Changes
Sponsored by: National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00445536
  Purpose

RATIONALE: Following the course of disease in patients with cancer or precancerous conditions who are receiving standard care may help the study of cancer in the future.

PURPOSE: This natural history study is looking at the course of disease in patients with cancer or precancerous conditions.


Condition Intervention
Brain and Central Nervous System Tumors
Leukemia
Lymphoma
Neuroblastoma
Precancerous/Nonmalignant Condition
Sarcoma
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific
Other: medical chart review
Procedure: observation

MedlinePlus related topics: Cancer Fungal Infections Hodgkin's Disease Leukemia, Adult Acute Leukemia, Adult Chronic Leukemia, Childhood Lymphoma Neuroblastoma Soft Tissue Sarcoma
U.S. FDA Resources
Study Type: Observational
Official Title: Treatment of Children With Cancer

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Natural history of disease [ Designated as safety issue: No ]

Estimated Enrollment: 250
Study Start Date: November 1998
Detailed Description:

OBJECTIVES:

  • To follow and evaluate patients, longitudinally with cancer or precancerous conditions referred to the NIH Clinical Center Pediatric Oncology Branch who present with disease manifestations that lend themselves to clinical evaluation and are of unique scientific importance.
  • To allow, when clinically indicated, patients to receive standard care therapies.

OUTLINE: Patients are evaluated at least every 3-6 months for up to 3 years and receive standard care as prescribed. Demographic information, histology, pathologic findings, and laboratory and imaging parameters are collected during that time. Blood, urine, or tumor specimens may be collected. Patients undergo periodic diagnostic x-rays and/or nuclear medicine scans.

Previous medical care data will be obtained and entered into a database.

PROJECTED ACCRUAL: A total of 250 patients will be accrued for this study.

  Eligibility

Ages Eligible for Study:   up to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of cancer or precancerous condition
  • Meets the following criteria:

    • Present with disease manifestations of special interest to NIH Clinical Center Pediatric Oncology Branch (POB) including, but not limited to, any of the following:

      • Lymphoma
      • Brain tumors
      • Ewings sarcoma
      • Leukemia
      • Neuroectodermal tumors
      • Osteosarcoma
      • Rhabdomyosarcoma

        • Patients between 30-40 years of age are only eligible if their condition is of specific interest to the POB

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Concurrent radiotherapy, surgery, or other medical treatment allowed
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00445536

Locations
United States, Maryland
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Recruiting
Bethesda, Maryland, United States, 20892-1182
Contact: Patient Recruitment     888-NCI-1937        
Sponsors and Collaborators
Investigators
Study Chair: Crystal Mackall, MD NCI - Pediatric Oncology Branch
  More Information

Additional Information:
No publications provided

Study ID Numbers: CDR0000078581, NCI-98-C-0037
Study First Received: March 7, 2007
Last Updated: February 6, 2009
ClinicalTrials.gov Identifier: NCT00445536     History of Changes
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
unspecified adult solid tumor, protocol specific
unspecified childhood solid tumor, protocol specific
precancerous/nonmalignant condition
recurrent adult Hodgkin lymphoma
stage I adult Hodgkin lymphoma
stage II adult Hodgkin lymphoma
stage III adult Hodgkin lymphoma
stage IV adult Hodgkin lymphoma
recurrent/refractory childhood Hodgkin lymphoma
stage I childhood Hodgkin lymphoma
stage II childhood Hodgkin lymphoma
stage III childhood Hodgkin lymphoma
stage IV childhood Hodgkin lymphoma
recurrent adult T-cell leukemia/lymphoma
stage I adult T-cell leukemia/lymphoma
stage II adult T-cell leukemia/lymphoma
stage III adult T-cell leukemia/lymphoma
stage IV adult T-cell leukemia/lymphoma
anaplastic large cell lymphoma
angioimmunoblastic T-cell lymphoma
recurrent mycosis fungoides/Sezary syndrome
stage I mycosis fungoides/Sezary syndrome
stage II mycosis fungoides/Sezary syndrome
stage III mycosis fungoides/Sezary syndrome
stage IV mycosis fungoides/Sezary syndrome
recurrent cutaneous T-cell non-Hodgkin lymphoma
stage I cutaneous T-cell non-Hodgkin lymphoma
stage II cutaneous T-cell non-Hodgkin lymphoma
stage III cutaneous T-cell non-Hodgkin lymphoma
stage IV cutaneous T-cell non-Hodgkin lymphoma

Study placed in the following topic categories:
Blast Crisis
Mantle Cell Lymphoma
Neoplasms, Connective and Soft Tissue
Leukemia, Prolymphocytic
Lymphoma, Large-Cell, Anaplastic
Neoplasm Metastasis
Neuroepithelioma
Rhabdomyosarcoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Astrocytoma
Leukemia, Myelomonocytic, Chronic
Leukemia, Myeloid
Ewing's Sarcoma
Brain Neoplasms
Brain Stem Glioma, Childhood
Waldenstrom Macroglobulinemia
Leukemia, Myeloid, Accelerated Phase
Sarcoma
Chronic Myelogenous Leukemia
Lymphoma, Non-Hodgkin
Neoplasms, Glandular and Epithelial
Choroid Plexus Neoplasms
Precancerous Conditions
Lymphoma, Follicular
Sezary Syndrome
Lymphoblastic Lymphoma
Neuroblastoma
Leukemia
Sarcoma, Ewing's
Soft Tissue Sarcomas

Additional relevant MeSH terms:
Neuroectodermal Tumors, Primitive
Precancerous Conditions
Neoplasms, Nerve Tissue
Central Nervous System Neoplasms
Neuroblastoma
Leukemia
Neoplasms, Connective and Soft Tissue
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Lymphoma, Large-Cell, Immunoblastic
Lymphoma
Nervous System Neoplasms
Neoplasms by Histologic Type
Immunoproliferative Disorders
Immune System Diseases
Nervous System Diseases
Lymphatic Diseases
Neuroectodermal Tumors
Neoplasms
Sarcoma
Lymphoproliferative Disorders
Lymphoma, Non-Hodgkin
Neoplasms, Neuroepithelial
Neuroectodermal Tumors, Primitive, Peripheral
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on May 06, 2009